Category: Prescription Drugs
Europe Prescription Drugs
-
Rx/Reimbursement Adult Incontinence in Slovakia
... doctor are fully reimbursed by an insurance company, and thus consumers are keen to obtain prescribed adult incontinence products where possible. More Slovakians are now aware of the price benefits of Rx/reimbursement incontinence products that ... Read More
-
Rx/Reimbursement Adult Incontinence in Serbia
... later in life. In tandem, rising inflation and the squeeze on disposable income has encouraged consumers to visit doctors and obtain Rx/reimbursements instead of purchasing adult incontinence themselves. Euromonitor International's Rx/Reimbursement adult incontinence in Serbia ... Read More
-
Rx/Reimbursement Adult Incontinence in Slovenia
... more individuals are seeking treatment in hospitals for incontinence issues. Additionally, heightened awareness has led to a growing number of younger individuals experiencing incontinence problems seeking medical attention. Postpartum women, in particular, are contributing to ... Read More
-
Rx/Reimbursement Adult Incontinence in Sweden
... public healthcare system, volume growth has been sluggish since the outbreak of COVID-19. In 2023, significant unit price increases dampened demand pushing volume growth rates below 2022 levels as the inflation rate in the country ... Read More
-
Rx/Reimbursement Adult Incontinence in Spain
... health and beauty specialists with the possibility of later reimbursement. In 2022 and 2023, adult incontinence products were among the most purchased packaged goods products that are funded by Spain’s Public Health system. As the ... Read More
-
Rx/Reimbursement Adult Incontinence in Poland
... sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, ... Read More
-
Rx/Reimbursement Adult Incontinence in Norway
... as energy, materials, labour, and shipping expenses. As manufacturers and retailers respond to these inflationary pressures by raising unit prices, the higher price levels contribute to the overall growth in value sales recorded in 2023. ... Read More
-
Rx/Reimbursement Adult Incontinence in Latvia
... often require assistance, including the use of adult incontinence products. As the elderly population grows, there is a corresponding surge in the demand for prescriptions and reimbursements for adult incontinence products, reflecting the essential role ... Read More
-
Rx/Reimbursement Adult Incontinence in Italy
... so-called “Community Health Houses” will be further decreased and, according to plans, this will be compensated by at-home assistance to patients and telemedicine. The aim of “Community Health Houses” is to offer nearby healthcare to ... Read More
-
Rx/Reimbursement Adult Incontinence in Hungary
... rising inflation, consumers were increasingly attracted to reimbursement above retail, allowing them to pay significantly less. This led to a rise in consumers seeking prescriptions for the products, with prescribed incontinence products part or completely ... Read More
-
Rx/Reimbursement Adult Incontinence in the Netherlands
... online, despite insurance reimbursement options available in the country. Retail e-commerce gives consumers the freedom to select their preferred brands and types. Moreover, under the RX/reimbursement model, basic incontinence pads and adult nappies/diapers are usually ... Read More
-
Rx/Reimbursement Adult Incontinence in Estonia
... associated with limited funding through Rx channels. Moderate/heavy adult incontinence products remained the preferred choice for consumers diagnosed with more severe incontinence issues, contributing to the overall positive performance of the product area. Euromonitor International's ... Read More
-
Rx/Reimbursement Adult Incontinence in Denmark
... supply chain constraints. Price increases were consistent with the observations across tissue and hygiene in the country, and more broadly with the general economy. Price increases boosted the magnitude of current value growth, while limiting ... Read More
-
Rx/Reimbursement Adult Incontinence in the Czech Republic
... to consumers for the condition, depending on the level of incontinence. Incontinence products are considered medical products under Czech law and are subsidised by health insurance companies if prescribed by doctors. As a result, price ... Read More
-
Rx/Reimbursement Adult Incontinence in France
... There was a small deceleration in the first year of the COVID-19 pandemic as consumers were more reluctant to go to the doctor, viewing surgeries or hospitals as a prime place to contract the virus. ... Read More
-
Europe Breast Cancer Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies)
... Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies) The ... Read More
-
Rx/Reimbursement Adult Incontinence in Belgium
... for such products. Additionally, the surge in demand for reimbursement for adult incontinence was catalysed by high inflation and financial instability experienced by some Belgians. Notably, on June 1st, 2023, the reimbursement amount saw an ... Read More
-
Pharmaceutical Market in Denmark 2024-2028
... market in Denmark provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Global Antibiotic Resistance Market, By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Others), By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The ... Read More
-
UK & Australia Dry Mouth Relief Market Research Report Forecast to 2032
... but rather a complication of several conditions, such as smoking, mouth bleeding, radiation damage to the head and neck, and adverse effects of specific medications. There are a variety of ways to treat a dry ... Read More
-
Finland Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... Medicines Agency, data updated in 2022, the COVID-19 pandemic in Finland did not significantly impacted medication availability. To avoid complications even if the situation persists, Finnish healthcare and pharmaceutical operators collaborated closely to prevent shortages. ... Read More
-
Epilepsy Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, ... Read More
-
Overweight Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Awareness and Strategic Partnerships Drive Demand for Overweight Treatment Solutions The global overweight treatment market is witnessing robust growth, fueled by a combination of factors including increased awareness among the morbidly obese population, strategic collaborations ... Read More
-
Statins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Dominates the Market, with the United States Leading in Statin Usage • Rising Obesity and Cardiovascular Disease Cases Boost Demand for Statins Worldwide The global statins market is on a steady growth trajectory and is ... Read More
-
Treatment Syndromes Dementia Movement Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) Leading Pharmaceutical Companies Aim to Address Rising Incidence of Cognitive Defects The global market for the treatment of syndromes related to dementia and movement disorders has witnessed remarkable growth in recent years, as ... Read More
Research Assistance
